FFCP PHASE1:Mm9::chr11:70250754..70250761,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP|EntrezGene=216869|HGNC=|MCL_coexpression_id=3|UniProt=|association_with_transcript=-32bp_to_ENSMUST00000143232_5end|description=CAGE_peak_9_at_Arrb2_5end|id=chr11:70250754..70250761,+|ontology_enrichment_celltype=CL:0000355!3.72e-07!9|ontology_enrichment_celltype_v019_2=CL:0000355,2.64e-15,9|ontology_enrichment_disease=DOID:0060100!2.21e-20!3;DOID:4045!2.21e-20!3;DOID:0050686!1.73e-10!6|ontology_enrichment_disease_v019_2=DOID:0060100,4.58e-44,3;DOID:4045,4.58e-44,3;DOID:0050686,1.60e-22,6|ontology_enrichment_uberon=UBERON:0001134!3.72e-07!9;UBERON:0002036!3.72e-07!9;UBERON:0002385!3.72e-07!9;UBERON:0000486!3.72e-07!9;UBERON:0001015!3.72e-07!9;UBERON:0004290!3.72e-07!9;UBERON:0003082!3.72e-07!9|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.64e-15,9;UBERON:0002036,2.64e-15,9;UBERON:0002385,2.64e-15,9;UBERON:0000486,2.64e-15,9;UBERON:0007503,2.64e-15,9;UBERON:0001015,2.64e-15,9;UBERON:0002329,2.64e-15,9;UBERON:0003082,2.64e-15,9;UBERON:0003059,2.64e-15,9;UBERON:0007282,2.64e-15,9;UBERON:0004290,2.64e-15,9;UBERON:0009618,2.64e-15,9;UBERON:0000383,7.43e-14,10;UBERON:0007524,1.14e-12,11;UBERON:0003077,1.14e-12,11;UBERON:0007285,1.14e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.62622750694888,3.906676722619,5.75876118371178,7.05877785637217,2.73218193983378,7.2826552954673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.449949858640699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192906610981141,0,0,0.214871054048298,0,0.441182838239031,0|short_description=p9@Arrb2}} | ||
|EntrezGene=216869 | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|UniProt= | |||
|association_with_transcript=-32bp_to_ENSMUST00000143232_5end | |||
|description=CAGE_peak_9_at_Arrb2_5end | |||
|id=chr11:70250754..70250761,+ | |||
|ontology_enrichment_celltype=CL:0000355!3.72e-07!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.64e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.21e-20!3;DOID:4045!2.21e-20!3;DOID:0050686!1.73e-10!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.58e-44,3;DOID:4045,4.58e-44,3;DOID:0050686,1.60e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!3.72e-07!9;UBERON:0002036!3.72e-07!9;UBERON:0002385!3.72e-07!9;UBERON:0000486!3.72e-07!9;UBERON:0001015!3.72e-07!9;UBERON:0004290!3.72e-07!9;UBERON:0003082!3.72e-07!9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.64e-15,9;UBERON:0002036,2.64e-15,9;UBERON:0002385,2.64e-15,9;UBERON:0000486,2.64e-15,9;UBERON:0007503,2.64e-15,9;UBERON:0001015,2.64e-15,9;UBERON:0002329,2.64e-15,9;UBERON:0003082,2.64e-15,9;UBERON:0003059,2.64e-15,9;UBERON:0007282,2.64e-15,9;UBERON:0004290,2.64e-15,9;UBERON:0009618,2.64e-15,9;UBERON:0000383,7.43e-14,10;UBERON:0007524,1.14e-12,11;UBERON:0003077,1.14e-12,11;UBERON:0007285,1.14e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.62622750694888,3.906676722619,5.75876118371178,7.05877785637217,2.73218193983378,7.2826552954673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.449949858640699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192906610981141,0,0,0.214871054048298,0,0.441182838239031,0 | |||
|short_description=p9@Arrb2 | |||
}} |
Revision as of 20:44, 12 September 2013
Short description: | p9@Arrb2 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_9_at_Arrb2_5end |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | -32bp_to_ENSMUST00000143232_5end |
EntrezGene: | Arrb2 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.64e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.64e-15 | 9 |
striated muscle tissue | 2.64e-15 | 9 |
muscle tissue | 2.64e-15 | 9 |
multilaminar epithelium | 2.64e-15 | 9 |
epithelial vesicle | 2.64e-15 | 9 |
musculature | 2.64e-15 | 9 |
somite | 2.64e-15 | 9 |
myotome | 2.64e-15 | 9 |
presomitic mesoderm | 2.64e-15 | 9 |
presumptive segmental plate | 2.64e-15 | 9 |
dermomyotome | 2.64e-15 | 9 |
trunk paraxial mesoderm | 2.64e-15 | 9 |
musculature of body | 7.43e-14 | 10 |
dense mesenchyme tissue | 1.14e-12 | 11 |
paraxial mesoderm | 1.14e-12 | 11 |
presumptive paraxial mesoderm | 1.14e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.58e-44 | 3 |
muscle cancer | 4.58e-44 | 3 |
organ system cancer | 1.60e-22 | 6 |
Property "Dpi dataset" (as page type) with input value "{{{DPIdataset}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.
Property "TSS like by RIKEN classifier" (as page type) with input value "{{{TSSclassifier}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.
Property "DHS support" (as page type) with input value "{{{DHSsupport}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.